Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Vandana Sachdev, MD, Yuan Gu, PhD, James Nichols, RN, Wen Li, RCS, Stanislav Sidenko, RCS, Darlene Allen, MT(ASCP), Colin Wu, PhD, Swee Lay Thein, DSc, MBBS

Blood (2019) 134 (Supplement_1): 893.

https://doi.org/10.1182/blood-2019-125846

Published: 2019

Journal Articles

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Caterina P. Minniti, MD, Vandana Sachdev, MD, Hannoush Hwaida, MD, Stanislav Sidenko, MD, Myron A Waclawiw, MD, Brenneman Cyndy, MD, Andrew E Arai, MD, Gregory J. Kato, MD, Jonathan R. Lindner, MD

Blood (2016) 128 (22): 1020.

https://doi.org/10.1182/blood.V128.22.1020.1020

Published: 2016

Journal Articles

Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease

Courtney Fitzhugh, MD, Hwaida Hannoush, MD, Vandana Sachdev, MD, Rosario Di Maggio, MD, Wynona Coles, RRT, Mary Link, RN, Evan Katradis, Xiongce Zhao, PhD, John F. Tisdale, MD, Matthew Hsieh, MD

Blood (2014) 124 (21): 4072.

https://doi.org/10.1182/blood.V124.21.4072.4072

Published: 2014

Journal Articles

Non-Cardiopulmonary Factors Affecting the Six-Minute Walk Distance in Patients with Sickle Cell Disease: Results From the Walk-PHaSST Study

Blood (2011) 118 (21): 1074.

https://doi.org/10.1182/blood.V118.21.1074.1074

Published: 2011

Journal Articles

Predictors of Six-Minute Walk Distance In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Robyn J. Barst, MD, Gregory J. Kato, MD, Vandana Sachdev, MD, Mehdi Nouraie, MD, Roberto F. Machado, MD, Kathryn Hassell, MD, Simon Gibbs, MD, Jane Little, MD, Dean E. Schraufnagel, MD, Lakshmanan Krishnamurti, MD, Reda E. Girgis, MD, Claudia R. Morris, MD, David B. Badesch, MD, Sophie Lanzkron, MD, MHS, Oswaldo Castro, MD, Erika Berman Rosenzweig, MD, Jonathan C. Goldsmith, MD, FACP, Mark Gladwin, MD, Victor R. Gordeuk, MD

Blood (2010) 116 (21): 947.

https://doi.org/10.1182/blood.V116.21.947.947

Published: 2010

Journal Articles

Sickle Cell Leg Ulcers Are Associated with Hyperuricemia, Hemolysis, Pulmonary Hypertension and Death.

Caterina P. Minniti, MD, Mariana Hildesheim, Vandana Sachdev, MD, Darlene Allen, Oswaldo Castro, MD, James G Taylor, VI, MD, Gregory J. Kato, MD

Blood (2009) 114 (22): 2583.

https://doi.org/10.1182/blood.V114.22.2583.2583

Published: 2009

Journal Articles

Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients with Sickle Cell Disease.

Vandana Sachdev, MD, Roberto F. Machado, MD, Yukitaka Shizukudu, MD, PhD, Yesoda Rao, MD, Stanislav Sidenko, Inez Ernst, RN, RDCS, Marilyn St. Peter, RDCS, Wynona A. Coles, RRT, Doug Rosing, MD, William C. Blackwelder, PhD, Oswaldo Castro, MD, Gregory J. Kato, MD, Mark T. Gladwin, MD

Blood (2005) 106 (11): 206.

https://doi.org/10.1182/blood.V106.11.206.206

Published: 2005

Journal Articles

Sodium Nitrite Increases Regional Blood Flow in Patients with Sickle Cell Disease.

A. Kyle Mack, MD, Roberto F. Machado, MD, Vandana Sachdev, MD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2005) 106 (11): 2328.

https://doi.org/10.1182/blood.V106.11.2328.2328

Published: 2005

Journal Articles

The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.

Oswaldo Castro, MD, Gregory Kato, MD, Vandana Sachdev, MD, Roberto Machado, MD, Inez Ernst, RN, Wynona A. Coles, RRT, James S. Nichols, RN, Lori A. Hunter, RN, Mark T. Gladwin, MD

Blood (2005) 106 (11): 314.

https://doi.org/10.1182/blood.V106.11.314.314

Published: 2005

Journal Articles

Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Christian Hunter, PhD, Lori Hunter, RN, Andre Dejam, MD, PhD, Roberto Machado, MD, Kyle Mack, MD, Jose Villagra, MD, James Nichols, RN, Wynona Coles, RT, Vandana Sachdev, MD, Richard Cannon, MD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 239.

https://doi.org/10.1182/blood.V104.11.239.239

Published: 2004

Journal Articles

Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Sabrina Martyr, BS, Roberto Machado, MD, Vandana Sachdev, MD, Inez Ernst, Lori Hunter, RN, Wynona Coles, RT, James Nichols, RN, Christian J. Hunter, PhD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 1669.

https://doi.org/10.1182/blood.V104.11.1669.1669

Published: 2004

NARROW

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease

Non-Cardiopulmonary Factors Affecting the Six-Minute Walk Distance in Patients with Sickle Cell Disease: Results From the Walk-PHaSST Study

Predictors of Six-Minute Walk Distance In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Sickle Cell Leg Ulcers Are Associated with Hyperuricemia, Hemolysis, Pulmonary Hypertension and Death.

Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients with Sickle Cell Disease.

Sodium Nitrite Increases Regional Blood Flow in Patients with Sickle Cell Disease.

The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.

Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.

Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only